Clinical Trial Update: Naltrexone and Behavioral Drug and HIV Risk Reduction Counseling in Russia [Phase 3]

View source ↗

Summary

Phase 3 trial investigating naltrexone with behavioral counseling for opiate dependence completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opiate Dependence

Drugs mentioned

• Naltrexone (Naltrexone)

Snippet

Sponsor: Yale University | Conditions: Opiate Dependence | Phase 3 | Status: COMPLETED